Skip to content

RxSight, Inc. RXST EBITDA margin

EBITDA margin at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
34.4%+2.7pp
LENSAR, Inc. logo
LENSAR, Inc.LNSR
-20.8%+6.8pp
Ocular Therapeutix logo
Ocular TherapeutixOCUL
-566.5%+1,247pp
Precision Optics Corporation logo
Precision Optics CorporationPOCI
-15.5%-5.1pp
Bausch + Lomb logo
Bausch + LombBLCO
12.4%+1.9pp
Glaukos logo
GlaukosGKOS
-28.5%+57.9pp

Other financials

Income statement

See full
Revenue$30.9M-18.5%
Gross profit$23.5M-17.1%
Operating income-$17.8M-67.0%
Net income-$15.9M-93.9%
EPS (diluted)-$0.38-90.0%

Balance sheet

See full
Cash & equivalents$17.6M-37.2%
Total debt$10.8M-10.1%
Total equity$267.3M-4.3%
Total assets$304.0M-2.9%

Cash flow

See full
Operating cash flow-$10.9M-23.3%
CapEx$759.0K+32.0%
Free cash flow-$11.7M-23.8%

Valuation

See full
Market cap$232.23M-56.8%
Enterprise value$225.49M-55.7%
P/S1.8×-1.8×

Profitability

See full
Gross margin77%+5.1pp
Operating margin-43.4%+128pp
Net margin-36.6%-867pp
FCF margin-16.9%+4.9pp

Returns & leverage

See full
Return on equity-17.1%+12.6pp
Debt / equity0.0×
Current ratio10.2×-2.5×

Where this comes from

Calculated from RxSight, Inc.’s reported figures.

Based on trailing twelve months.

The official record: RxSight, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about RxSight, Inc.'s ebitda margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is RxSight, Inc.'s EBITDA margin?
RxSight, Inc. (RXST) reported EBITDA margin of -40.8% in Q1 2026.
How has RxSight, Inc.'s EBITDA margin changed year-over-year?
RxSight, Inc.'s EBITDA margin decreased by 80.0% year-over-year, from -22.7% to -40.8%.
What is the long-term trend for RxSight, Inc.'s EBITDA margin?
Over 4 years (2021 to 2025), RxSight, Inc.'s EBITDA margin has grown at a -37.3% compound annual growth rate (CAGR), from -216% to -33.4%.
What does EBITDA margin mean?
EBITDA (earnings before interest, taxes, depreciation, and amortization) as a percentage of revenue, trailing twelve months. A proxy for cash operating profitability that strips out capital-structure and non-cash charges.